22 July 2015
Swindon Team involved in internationally recognised dementia delay drug.
A team based at the Victoria
Centre in Swindon has been involved in the new drug which could
The Kingshill Research Centre is Avon & Wiltshire Mental
Health Partnership Trust's clinical trials centre. Kingshill has
been involved in trialling the new drug, which may cut the rate of
the dementia's progression in a third of people with early onset
Kingshill's participation with the study has spanned 5 years and
it brings great satisfaction to the team to see the study results
published today and the international media coverage that has
Emma Murray, Clinical Trial Administrator said "When the study
started in 2010 we recruited ten patients who participated in a
monthly infusion. We are now about to enter the next phase of the
study and look forward to being able to give more service users the
opportunity to be involved in dementia research studies."
The Kingshill Research Centre specialises in trialling dementia
drugs. The team has been involved in most clinical trials for drugs
routinely used by people with a dementia diagnosis. Clinical trials
help us evaluate the safety and effectiveness of new drugs, as well
as looking at combinations of new and existing drugs or how they
work in other conditions.